News

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...
Jim Cramer once confidently backed Pfizer, praising its pipeline and high dividend, forecasting a big post-COVID comeback. “I ...
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...
Payal Sahni Becher is currently the Chief People Experience Officer & Executive VP at Pfizer Inc. She started this position in 2022. Prior to her current role, she obtained a graduate degree from ...
Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...
According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.
Zacks Investment Research on MSN10d
Should Value Investors Buy Pfizer (PFE) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...
Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...
Pfizer is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years.Shares are down 19% over the past ...